- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Sustainable Track Record
Canadian Pharmaceuticals & Biotech Sustainable Track Record
Results
2
1 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
BioSyent
Market Cap: CA$135.9m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$12.07
7D
0.5%
1Y
11.2%
Simply Solventless Concentrates
Market Cap: CA$43.3m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
New
HASH
CA$0.38
7D
15.4%
1Y
-25.0%